Cell surface-engineering to embed targeting ligands or tracking agents on the cell membrane

Area of Science:

• Biotechnology
• Regenerative Medicine
• Cell Biology

Background:

• Improving cell therapy efficacy requires efficient methods to guide cells to target tissues.
• Current methods for cell modification can be invasive or limited in scope.

Purpose of the Study:

• To develop a novel, non-invasive cell surface engineering technology.
• To enable the modification of various cell types with bioactive molecules for targeted delivery and tracking.

Main Methods:

• Developed a cell surface engineering technique to embed bioactive molecules onto cell surfaces.
• Modified mesenchymal stem cells (MSCs) with homing peptides/recombinant proteins for targeting.
• Labeled MSCs with magnetic resonance imaging (MRI) contrast agents for in vivo tracking.

Main Results:

• Engineered MSCs successfully migrated towards specific molecular targets when modified with homing peptides or targeting ligands.
• MRI contrast agents were effectively embedded on MSC surfaces without compromising cell viability.
• Labeled MSCs were successfully detected in vivo using MRI.

Conclusions:

• The developed cell surface engineering technology is a versatile and promising approach for enhancing cell therapies.
• This technology facilitates targeted cell migration and allows for non-invasive monitoring of cell distribution in vivo.
• Applicable to a broad range of cell therapies across various disease states.